Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,077 public trials 1,842 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Active, Not Recruiting

Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

NCT03391869

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +15 more
Locations
  • MD Anderson in The Woodlands Conroe, Texas, United States
  • M D Anderson Cancer Center Houston, Texas, United States
  • MD Anderson West Houston Houston, Texas, United States
  • MD Anderson League City League City, Texas, United States
View Trial Details
Active, Not Recruiting

Targeted Treatment for RET Fusion-Positive Advanced Non-Small Cell Lung Cancer (A LUNG-MAP Treatment Trial)

NCT04268550

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
  • Sutter Auburn Faith Hospital Auburn, California, United States
View all 306 locations
View Trial Details
Active, Not Recruiting

CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung

NCT05306288

Conditions
Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
Locations
  • Cullman Clinical Trials Cullman, Alabama, United States
  • Science 37 (nationwide digital enrollment) Culver City, California, United States
  • Providence Facey Medical Foundation Mission Hills, California, United States
  • Hoag Hospital Newport Beach, California, United States
View all 67 locations
View Trial Details
Active, Not Recruiting

Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in Non-Small Cell Lung Cancer (NSCLC)

NCT04379635

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Peking University Peoples Hospital Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Xuanwu Hospital Capital Medical University Beijing, Beijing Municipality, China
View all 44 locations
View Trial Details
Active, Not Recruiting

Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004)

NCT06726265

Conditions
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC), Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Norton Cancer Institute - Audubon Louisville, Kentucky, United States
  • New Mexico Oncology Hematology Consultants, Ltd. Albuquerque, New Mexico, United States
  • Ascension Seton Infusion Center Austin, Texas, United States
  • Centro de Endocrinologia y Diabetes Dr. Raul A. Gutman SRL Buenos Aires, Argentina
View all 147 locations
View Trial Details

Related conditions